All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-38748198

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38748198	D144A	S	S	Hepatitis B Virus Infection	G R S I C L	View
2	38748198	E258D	RT	P	Hepatitis B Virus Infection	G R S C L	View
3	38748198	G294R	RT	P	Hepatitis B Virus Infection	G R S C L	View
4	38748198	H52Y	X	X	Hepatitis B Virus Infection	G R S C L	View
5	38748198	H580Q	RT	P	Hepatitis B Virus Infection	G R S C L	View
6	38748198	I226S	S	S	Hepatitis B Virus Infection	G R S C L	View
7	38748198	I515L	RT	P	Hepatitis B Virus Infection	G R S C L	View
8	38748198	K160N	S	S	Hepatitis B Virus Infection	G R S I C L	View
9	38748198	P583S	RT	P	Hepatitis B Virus Infection	G R S C L	View
10	38748198	S174N	S	S	Hepatitis B Virus Infection	G R S C L	View
11	38748198	S21W	S	S	Hepatitis B Virus Infection	G R S C L	View
12	38748198	S78I	PreS1	S	Hepatitis B Virus Infection	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.